OpenArc Corporate Advisory’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
OpenArc Corporate Advisory's IDXX Position: Q2 2026 in Review
OpenArc Corporate Advisory increased its Idexx Laboratories (IDXX) stake by 25% in Q2 2026, buying an estimated $63.4K and bringing the position to 570 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #629.
OpenArc Corporate Advisory first reported a position in IDXX in Q4 2025 and has held it in 3 quarters since. The position peaked at $385K in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- OpenArc Corporate Advisory held 570 shares of Idexx Laboratories worth $300K as of Q2 2026.
- OpenArc Corporate Advisory bought 113 Idexx Laboratories shares in Q2 2026, an estimated $63.4K.
- Idexx Laboratories made up ﹤0.01% of OpenArc Corporate Advisory's portfolio in Q2 2026, its #629 holding.
- OpenArc Corporate Advisory first reported a position in Idexx Laboratories in Q4 2025 and has held it in 3 quarters since.
- OpenArc Corporate Advisory's Idexx Laboratories position peaked at $385K in Q4 2025.
- 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.